Physician

Mark Joseph Stavas, MD

According to 2025 Medicare claims, Mark Stavas, MD (NPI: 1336468636) practices radiation oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is CANCER PARTNERS OF NEBRASKA PC (NPI: 1437111408; TIN: 911862785) and primary practice location at 68516-5587. Stavas is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Stavas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 591 traditional Medicare patients, billed 7,802 HCPCS/CPT codes, and received $1,283,266 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 277 prescription claims across 97 beneficiaries totaling $3,284 in drug costs, led by Dexamethasone (Dexamethasone). Open Payments data shows 17 records totaling $306. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $24,763 to $1,283,266. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,019 and ending at $3,284. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	47	264	$24,763
2016	152	660	$64,543
2017	246	1,211	$121,503
2018	257	3,985	$718,670
2019	350	5,961	$1,012,679
2020	460	10,044	$1,381,029
2021	511	6,409	$1,142,524
2022	545	7,099	$1,283,612
2023	541	7,179	$1,172,197
2024	591	7,802	$1,283,266

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	11	$1,019
2016	15	27	$724
2017	24	46	$1,110
2018	54	150	$3,823
2019	84	301	$10,668
2020	76	281	$9,656
2021	89	255	$5,226
2022	94	321	$9,629
2023	101	281	$7,052
2024	97	277	$3,284

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	152	429	$138
77263	Complex radiation therapy planning	145	154	$120
77014	Ct guidance for insertion of radiation therapy fields	137	912	$86
77336	Continuing radiation therapy consultation per week	166	379	$62
77300	Calculation of radiation therapy dose	146	445	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dexamethasone	Dexamethasone	46	888	$543
Tamsulosin Hcl	Tamsulosin Hcl	24	1,500	$236
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	142	$230
Methylprednisolone	Methylprednisolone	16	96	$171
Gabapentin	Gabapentin	23	649	$163

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$306	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Joseph Stavas, MD?

Tedicare shows public-source Medicare data for Mark Joseph Stavas, MD (NPI 1336468636), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Joseph Stavas, MD have ACO affiliation data?

Mark Joseph Stavas, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Mark Joseph Stavas, MD?

Mark Joseph Stavas, MD is linked to CANCER PARTNERS OF NEBRASKA PC (billing NPI 1437111408) in the available physician profile data.

Does Mark Joseph Stavas, MD have Open Payments data?

Mark Joseph Stavas, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.